Scientific Research and Development

The Scientific Research and Development team at Horizon focuses on advancing innovative therapies for ultra-rare diseases through rigorous biostatistical analysis, clinical science research, and the development of immunoassays. This multidisciplinary team collaborates to design and implement clinical trials, interpret complex data, and support the scientific foundation needed for regulatory submissions and product development, ultimately aiming to enhance patient outcomes in underrepresented therapeutic areas.